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Background
Detection of CMV DNA in DBS (Guthrie cards) has been
proposed for neonatal diagnosis of CMV congenital infec-
tion.
Objectives
To evaluate the in vitro sensitivity of 2 methods of CMV
DNA detection in DBS. To evaluate the specificity and the
sensitivity of these 2 methods for congenital CMV diagno-
sis in comparison to the gold standard method (CMV
detection in urine).
Methods
To study in vitro sensitivity, "test cards" were prepared
with dilutions of pre-quantified whole blood samples. To
study in vivo specificity and sensitivity, 215 neonates who
had CMV congenital infection diagnosis done by PCR or
culture in a urine sample collected in the first week of life
were included prospectively. Fourty-five of these neonates
had positive CMV detection in their urine (by PCR
(Necker, Poissy, Béclère) or by rapid culture (IPP). CMV
DNA was detected in the Guthrie cards by 2 methods.
Method 1 consisted of DNA extraction in a whole DBS
with NaOH 0.32% lysis followed by QIAamp DNA Blood
Mini Kit and amplification by an in house real time PCR
in duplicate. Method 2 was a phenol/chloroform extrac-
tion of a whole DBS followed by amplification with the
CMV PCR kit (Abbott, France).
Results
The 95% sensitivity of the 2 methods was 4000 and 2000
copies/ml respectively. In neonates, sensitivity and specif-
icity of method 1 were 100% (45/45) and 96.9% (160/
165) when at least one duplicate was positive and 88.8%
(40/45) and 100% (165/165) when the two duplicates
were positive. Sensitivity and specificity of method 2 were
95.1% (39/41) and 97.5% (158/162) respectively. Results
were discordant (negative detection in urine and positive
PCR in DBS) in 8 cards from 8 different neonates (4 with
method 1 and 4 with method 2), these false positive were
not repeatable when retested. Mean viral load of the 8
false positive were 376 [280–500] and 31 [9–53] copies/
ml with method 1 and method 2 respectively. In one case,
the CMV PCR in DBS was repeatedly positive with the 2
methods, whereas it was negative in the urine at birth by
rapid culture. This case was considered as a false negative
of the rapid culture and was therefore excluded from the
analysis.
Conclusion
Sensitivity of CMV DNA detection in DBS was very high
when PCR was done in duplicate. However, when only
one duplicate was positive it could be a false positive
result. Low positive results needed to be confirmed by a
second testing. In these best conditions, we think that
these 2 methods are sensitive and specific enough for neo-
natal diagnosis of CMV congenital infection and for retro-
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